Skip to main
NBY
NBY logo

NovaBay Pharmaceuticals (NBY) Market Capitalization Overview

Market Cap: $3.75M as of Jun 12, 2025

$3.75M
Past Month+$543.80K (17.00%)
As of Jun 12, 2025, NovaBay Pharmaceuticals (NBY) has a market capitalization of $3.75M. Over the past 30 days, its market cap has decreased by -6.1%, while in the last 12 months, it has increased by 27.48%.

Market capitalization represents the total value of NovaBay Pharmaceuticals as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

NovaBay Pharmaceuticals (NBY) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of NovaBay Pharmaceuticals (NBY) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

NovaBay Pharmaceuticals (NBY) Market Cap History

DateMarket CapChange
Jun 2, 2025$3.23M-6.10%
May 1, 2025$3.44M+0.84%
Apr 1, 2025$3.41M+19.95%
Mar 3, 2025$2.84M-12.59%
Feb 3, 2025$3.25M+6.29%
Jan 2, 2025$3.06M+3.98%

NovaBay Pharmaceuticals (NBY) End of Year Market Cap History

DateMarket CapChange
2025$3.75M+27.48%
2024$2.94M+120.46%
2023$1.34M-63.22%
2022$3.63M-79.87%
2021$17.99M-38.23%
2020$29.13M

FAQs About NovaBay Pharmaceuticals (NBY) Market Cap

As of Jun 12, 2025, the market capitalization of NovaBay Pharmaceuticals (NBY) is $3.75M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, NovaBay Pharmaceuticals’s market capitalization has increased by 17.00%, changing from $3.20M to $3.75M as of Jun 12, 2025.

In the last 3 months, NovaBay Pharmaceuticals’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, NovaBay Pharmaceuticals’s market capitalization increased from $1.34M in January to $2.94M in December, reflecting a 120.46% change.

In the past five years, NovaBay Pharmaceuticals (NBY) has had a compound annual growth rate (CAGR) of -36.80% in market capitalization. This means its market cap has shrunk at an average rate of -36.80% per year.

NovaBay Pharmaceuticals (NBY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.